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ABSTRACT: Orthogonally linked BODIPY units show exceptional intersystem
crossing efficiencies. We now report orthogonal BODIPY trimers with strong absorption
in the visible region and high singlet oxygen generation capability. The X-ray diffraction
structure confirms that the two peripheral BODIPY units are at a perpendicular angle to
the core structure.
BODIPY dyes have grown to become a family ofcompounds with diverse applications rivaling that of
porphyrins.1 From chemosensors to logic gates,2 photodynamic
therapy (PDT) agents3 to dye-sensitized solar cell (DSSC)
photosensitizers,4 simple derivatives of BODIPY have proven
to be quite valuable. In addition, with slight core modifications,
such as expanded rings5 or pyridine substitutions,6 chemical
diversity can be further enhanced. A broad palette of colors
(S0−S1 transition) can be obtained through straightforward
derivatizations.7
As a part of our ongoing efforts toward improved
photosensitizers for photodynamic therapy,8 we recently
reported9 that orthogonal Bodipy dimers have unique
“degenerate” excited-state characteristics which make them
exceptionally effective in photosensitized generation of singlet
oxygen. This leads to a significant step in the right direction
because incorporation of heavy atoms to facilitate intersystem
crossing (isc) often results in increased dark toxicity10 (i.e.,
toxicity of the photosensitizer compound itself, in the absence
of light). Thus, the orthogonal dimer approach appears to be a
straightforward methodology for the transformation of an
ordinary dye into an effective photosensitizer, without heavy
atom incorporation.
It is important to probe the limitations11 of this approach
both theoretically and experimentally. We were pleased to
report12 that simple derivatives of the orthogonal dimers
covalently attached to upconverting nanoparticles (ucnp) can
be excited at 980 nm to generate singlet oxygen, which makes
the orthogonal Bodipy dimer−ucnp conjugates viable candi-
dates as potential sensitizing agents for PDT.
It would be equally important to investigate an orthogonal
Bodipy trimer as a model for extended orthogonality. To that
end, we targeted compounds 5a and 5b for synthesis. The
synthesis work (Figure 1) for 5a started with a commercially
available aldehyde, p-tert-butylbenzaldehyde. tert-Butyl sub-
stituents may contribute to organic solubility and also facilitate
formation of crystals suitable for X-ray analysis. Construction of
the Bodipy core in accordance with the well-established
procedures13 results in compound 2a. Two consecutive
Villsmeyer−Haack-type formylations14 give 2,6-diformyl de-
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Figure 1. Synthesis of the orthogonal Bodipy trimers 5a and 5b.
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rivative 4a. This compound was then converted to the target
trimer (5a) by applying the usual BODIPY synthesis protocol.
Compound 5b was synthesized similarly, with only difference
being the use of 4-(5-hydroxypentyl)benzaldehyde (1b) instead
of 1a. The trimer 5b was targeted for an additional potential for
further functionalization. Both target compounds were
characterized analytically (1H, 13C, and HRMS, see the
Supporting Information). The absorption spectrum of 5a in
dichloromethane (DCM) shows a major band in the visible
region with a peak at 507 nm and a shoulder at 522 nm. The
extinction coefficient at 507 nm is 181500 cm−1 M−1. Crystals
of 5a suitable for single-crystal X-ray diffraction study were
obtained by slow evaporation of the DCM solution. The X-ray
structure of the compound 5a reveals three orthogonal planes
defined by the meso-tert-butylphenyl substituent, the core
BODIPY plane, and the planes defined by the peripheral
BODIPY units. The angles between these planes are essentially
perpendicular to each other as expected (Figure 2). Our
previous computational work suggests that although the
peripheral BODIPY units are placed at about an 80° angle
(i.e., less than 90°) in relation to the BODIPY core it is enough
to cause degeneracy in the excited state.
A solution of compound 5a in DCM solution sensitized
dissolved oxygen, and the characteristic phosphorescence
emission of singlet oxygen at 1270 nm was detected (SI). By
using 1,3-diphenylisobenzofuran as a singlet oxygen trap,
relative singlet oxygen generation capacities were determined.
1,3-Diphenylisobenzofuran is a selective trap for singlet oxygen.
The reaction proceeds with an initial [4 + 2] cycloaddition of
the singlet oxygen, as isobenzofurans are one of the most
reactive dienes in such cycloaddition reactions due to
aromatization in the cycloadduct (Figure 3). The intermediate
species is unstable, and it decomposes into 1,2-dibenzoylben-
zene. The net result is a decrease in the absorption of iso-
benzofuran (Figure 4); thus, the progress of the reaction can be
followed at 410 nm (Figure 5).
Singlet oxygen quantum yields of both compounds in DCM
were determined as 0.53 for 5a and 0.55 for 5b. Thus, we were
able to show that orthogonality of the chromophores in the
compounds 5a and 5b resulted in degenerate excited states
Figure 2. (Top) X-ray diffraction structure of the BODIPY-trimer 5a.
(Bottom) Planes defined by the peripheral BODIPY units (red) are at
an 81−82° angle to the core unit (blue structure), whereas the meso-
phenyl substituent is at a 90° angle to the same core BODIPY plane.
Figure 3. Reaction of 1,3-diphenylisobenzofuran (DPBF) with singlet
oxygen leading to the decrease in the absorbance at 414 nm.
Figure 4. Decrease in the absorbance of the singlet oxygen trap DPBF
in DCM solution at the peak absorbance of the trap compound in the
presence of 5a. When kept in the dark absorbance does not change;
however, once irradiation begins, in 4 min, 90% of the DPBF
disappears. Concentration of the trimer 5a was 0.77 μM, and the
DPBF concentration is 56.6 μM. The irradiation was carried out using
a green LED array with a fluence rate of 2.5 mW/cm2.
Figure 5. Plot of absorbance as a function of time at the maximum of
the DPBF peak at 414 nm in the presence of 0.77 μM trimer 5a. The
experiment was carried out under green LED excitation with a fluence
rate of 2.5 mW/cm2. The initial concentration of the DPBF
concentration was set at 56.6 μM.
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with facilitated intersystem crossing to yield efficient singlet
oxygen generators. Functionalization in 5b also reveals that it
should be possible to use the trimer compound as a
photosensitizer module and attach it to molecular entities or
to nanoparticles as needed. Since it is important to have a
general approach for the design of efficient photosensitizers
without the incorporation of heavy atoms, the orthogonally
chromophores are likely to be at the center of attention.
In addition to the photosensitizing properties of the target
compounds, it is also clear that the orthogonal BODIPY trimers
can be utilized as chromogenic structural units. As the 2,6-
positions of the peripheral BODIPY units are open to
substitution, it is very likely that well-defined organic
frameworks can be obtained by various coupling reactions.
Further work along these lines is in progress and will be
reported in due course.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.or-
glett.6b02418.
Synthesis procedures; additional spectral and character-
ization data, including 1H and 13C NMR and HRMS data
(PDF)





⊥(J.L.B.) EPFL SB ISIC LCS BCH 3409 (Batochime UNIL),
Av. F.-A. Forel 2, CH-1015 Lausanne, Switzerland.
Notes
The authors declare no competing financial interest.
■ ACKNOWLEDGMENTS
Financial support by Bilkent University in the form of a
graduate student scholarship to J.L.B. is gratefully acknowl-
edged.
■ REFERENCES
(1) (a) Rurack, K.; Kollmannsberger, M.; Daub, J. Angew. Chem., Int.
Ed. 2001, 40, 385−387. (b) Ziessel, R.; Ulrich, G.; Harriman, A. New J.
Chem. 2007, 31, 496−501. (c) Atilgan, S.; Kutuk, I.; Ozdemir, T.
Tetrahedron Lett. 2010, 51, 892−894. (d) Bozdemir, O. A.; Cakmak,
Y.; Sozmen, F.; Ozdemir, T.; Siemiarczuk, A.; Akkaya, E. U. Chem. -
Eur. J. 2010, 16, 6346−6351. (e) Ozdemir, T.; Sozmen, F. RSC Adv.
2016, 6, 10601−10605. (f) Ozdemir, T.; Sozmen, F.; Mamur, S.;
Tekinay, T.; Akkaya, E. U. Chem. Commun. 2014, 50, 5455−5457.
(g) Zeng, L.; Miller, E. W.; Pralle, A.; Isacoff, E. Y.; Chang, C. J. J. Am.
Chem. Soc. 2006, 128, 10−11.
(2) (a) Sunahara, H.; Urano, Y.; Kojima, H.; Nagano, T. J. Am. Chem.
Soc. 2007, 129, 5597−5604. (b) Yin, S. C.; Leen, V.; Van Snick, S.;
Boens, N.; Dehaen, W. Chem. Commun. 2010, 46, 6329−6331.
(c) Rurack, K.; Kollmannsberger, M.; Resch-Genger, U.; Daub, J. J.
Am. Chem. Soc. 2000, 122, 968−969. (d) Isik, M.; Ozdemir, T.; Turan,
I.S.; Kolemen, S.; Akkaya, E. U. Org. Lett. 2013, 15, 216−219. (e) Niu,
L.-Y.; Guan, Y.-S.; Chen, Y.-Z.; Wu, L.-Z.; Tung, C.-H.; Yang, Q.-Z. J.
Am. Chem. Soc. 2012, 134, 18928−18931. (f) Gabe, Y.; Urano, Y.;
Kikuchi, H.; Kojima, H.; Nagano, T. J. Am. Chem. Soc. 2004, 126,
3357−3367. (g) Guliyev, R.; Ozturk, S.; Kostereli, Z.; Akkaya, E. U.
Angew. Chem., Int. Ed. 2011, 50, 9826−9831. (h) Erbas-Cakmak, S.;
Bozdemir, O. A.; Cakmak, Y.; Akkaya, E. U. Chem. Sci. 2013, 4, 858−
862.
(3) (a) Kamkaew, A.; Lim, S. H.; Lee, H. B.; Kiew, L. V.; Chung, L.
Y.; Burgess, K. Chem. Soc. Rev. 2013, 42, 77−88. (b) Yogo, T.; Urano,
Y.; Ishitsuka, F.; Nagano, T. J. Am. Chem. Soc. 2005, 127, 12162−
12163. (c) Gallagher, W. M.; Allen, L. T.; O’Shea, C.; Kenna, T.; Hall,
M.; Gorman, A.; Killoran, J.; O’Shea, D. F. Br. J. Cancer 2005, 92,
1702−1710. (d) Young, S. W.; Woodburn, K. W.; Wright, M.; Mody,
T. D.; Fan, Q.; Sessler, J. L.; Dow, W. C.; Miller, R. A. Photochem.
Photobiol. 1996, 63, 892−897. (e) Tan, X.; Luo, S.; Wang, D.; Su, Y.;
Cheng, T.; Shi, C. Biomaterials 2012, 33, 2230−2239. (f) Yang, Y.;
Guo, Q.; Chen, H.; Zhou, Z.; Guo, Z.; Shen, Z. Chem. Commun. 2013,
49, 3940−3942.
(4) (a) Kumaresan, D.; Thummel, R. P.; Bura, T.; Ulrich, G.; Ziessel,
R. Chem. - Eur. J. 2009, 15, 6335−6339. (b) Lee, C. Y.; Hupp, J. T.
Langmuir 2010, 26, 3760−3765. (c) Kolemen, S.; Bozdemir, O. A.;
Cakmak, Y.; Barin, G.; Erten-Ela, S.; Marszalek, M.; Yum, J. H.;
Zakeeruddin, S. M.; Nazeeruddin, M. K.; Graetzel, M.; Akkaya, E. U.
Chem. Sci. 2011, 2, 949−954. (d) Rousseau, T.; Cravino, A.; Bura, T.;
Ulrich, G.; Ziessel, R.; Roncali, J. Chem. Commun. 2009, 1673−1675.
(e) He, J.; Benko, G.; Korodi, F.; Polivka, T.; Lomoth, R.; Akermark,
B.; Sun, L.; Hagfeldt, A.; Sundstrom, V. J. Am. Chem. Soc. 2002, 124,
4922−4932. (f) Hattori, S.; Ohkubo, K.; Urano, Y.; Sunahara, H.;
Nagano, T.; Wada, Y.; Tkachenko, N. V.; Lemmetyinen, H.;
Fukuzumi, S. J. Phys. Chem. B 2005, 109, 15368−15375. (g) Erten-
Ela, S.; Yilmaz, D.; Icli, B.; Dede, Y.; Icli, S.; Akkaya, E. U. Org. Lett.
2008, 10, 3299−3302.
(5) (a) Guliyev, R.; Ozturk, S.; Sahin, E.; Akkaya, E. U. Org. Lett.
2012, 14, 1528−1531. (b) Majumdar, P.; Mack, J.; Nyokong, T. RSC
Adv. 2015, 5, 78253−7825.
(6) (a) Loudet, A.; Burgess, K. Chem. Rev. 2007, 107, 4891−4932.
(b) Xu, J.; Li, Q.; Yue, Y.; Guo, Y.; Shao, S. Biosens. Bioelectron. 2014,
56, 58−63. (c) Wagner, S.; Brödner, K.; Coombs, B. A.; Bunz, U. H. F.
Eur. J. Org. Chem. 2012, 2012, 2237−2242.
(7) (a) Loudet, A.; Burgess, K. Chem. Rev. 2007, 107, 4891−4932.
(b) Ulrich, G.; Ziessel, R.; Harriman, A. Angew. Chem., Int. Ed. 2008,
47, 1184−1201. (c) Buyukcakir, O.; Bozdemir, O. A.; Kolemen, S.;
Erbas, S.; Akkaya, E. U. Org. Lett. 2009, 11, 4644−4647. (d) Zhu, S.;
Zhang, J.; Vegesna, G.; Tiwari, A.; Luo, F.-T.; Zeller, M.; Luck, R.; Li,
H.; Green, S.; Liu, H. RSC Adv. 2012, 2, 404−407. (e) Bura, T.;
Retailleau, P.; Ulrich, G.; Ziessel, R. J. Org. Chem. 2011, 76, 1109−
1117.
(8) (a) Erbas, S.; Gorgulu, A.; Kocakusakogullari, M.; Akkaya, E. U.
Chem. Commun. 2009, 4956−4958. (b) Atilgan, S.; Ekmekci, Z.;
Dogan, A. L.; Guc, D.; Akkaya, E. U. Chem. Commun. 2006, 4398−
4400. (c) Erbas, S.; Gorgulu, A.; Kocakusakogullari, M.; Akkaya, E. U.
Chem. Commun. 2009, 4956−4958. (d) Ozlem, S.; Akkaya, E. U. J. Am.
Chem. Soc. 2009, 131, 48−49. (e) Turan, I. S.; Yildiz, D.; Turksoy, A.;
Gunaydin, G.; Akkaya, E. U. Angew. Chem., Int. Ed. 2016, 55, 2875−
2878. (f) Kolemen, S.; Ozdemir, T.; Lee, D.; Kim, G. M.; Karatas, T.;
Yoon, J.; Akkaya, E. U. Angew. Chem. 2016, 128, 3670−3674.
(9) (a) Cakmak, Y.; Kolemen, S.; Duman, S.; Dede, Y.; Dolen, Y.;
Kilic, B.; Kostereli, Z.; Yildirim, L. T.; Dogan, A. L.; Guc, D.; Akkaya,
E. U. Angew. Chem., Int. Ed. 2011, 50, 11937−11941. (b) Kolemen, S.;
Isik, M.; Kim, G. M.; Kim, D.; Geng, H.; Buyuktemiz, M.; Karatas, T.;
Zhang, X.-F.; Dede, Y.; Yoon, J.; Akkaya, E. U. Angew. Chem., Int. Ed.
2015, 54, 5340−5344.
(10) (a) Lim, S. H.; Thivierge, C.; Nowak-Sliwinska, P.; Han, J. Y.;
van den Bergh, H.; Wagnieres, G.; Burgess, K.; Lee, H. B. J. Med.
Chem. 2010, 53, 2865−2874.
(11) Duman, S.; Cakmak, Y.; Kolemen, S.; Akkaya, E. U.; Dede, Y. J.
J. Org. Chem. 2012, 77, 4516−4527.
(12) Topel, S. D.; Cin, G. T.; Akkaya, E. U. Chem. Commun. 2014,
50, 8896−8899.
(13) Tram, K.; Yan, H. B.; Jenkins, H. A.; Vassiliev, S.; Bruce, D. Dyes
Pigm. 2009, 82, 392−395.




Org. Lett. 2016, 18, 4821−4823
4823
